MiMedx commenced patient enrollment in a Phase III Investigational New Drug clinical trial of AmnioFix® Injectable in the treatment of Achilles Tendonitis.
Enrollment, slightly delayed from the previously-expected 4Q17 launch, will include ~158 subjects in this prospective, double blinded, randomized controlled trial of Micronized dehydrated Human Amnion Chorion Membrane Injection vs. saline placebo. Following completion, MiMedx plans to submit a Biologic License Application to FDA.
MiMedx commenced patient enrollment in a Phase III Investigational New Drug clinical trial of AmnioFix® Injectable in the treatment of Achilles Tendonitis.
MiMedx commenced patient enrollment in a Phase III Investigational New Drug clinical trial of AmnioFix® Injectable in the treatment of Achilles Tendonitis.
Enrollment, slightly delayed from the previously-expected 4Q17 launch, will include ~158 subjects in this prospective, double blinded, randomized controlled trial of Micronized dehydrated Human Amnion Chorion Membrane Injection vs. saline placebo. Following completion, MiMedx plans to submit a Biologic License Application to FDA.
Copy to clipboard 
